S. GAIL ECKHARDT was named the inaugural director of the LIVESTRONG Cancer Institutes of the Dell Medical School at the University of Texas at Austin. She was also appointed associate dean of the medical school. The appointment was made possible by a $6 million recruitment grant from the Cancer Prevention and Research Institute of Texas....
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
